In a recent report, IFN-γ was found to be increased in CSF from patients with MS, whereas increased IL-17 was detected in serum [14], suggesting that the Th1 response plays a more critical role in orchestrating the MS immunopathological cascade. This evidence concerns the gene IFNG and myeloid sarcoma.